[1
]Servicio Aparato Digestivo and Servicio de Farmacología Clínica, Instituto de Investigación
Biomédica de Málaga-IBIMA_Plataforma Bionand, Hospital Universitario Virgen de la
Victoria, Universidad de Málaga, Málaga, Spain
[2
]Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd),
Madrid, Spain
[3
]Nottingham Digestive Diseases Centre, Translational Medical Sciences, School of Medicine;
NIHR Nottingham Biomedical Research Centre, Nottingham University Hospitals NHS Trust
and the University of Nottingham, Nottingham, UK
[4
]Department of Gastroenterology and Hepatology, Amsterdam University Medical Centers,
VU University Medical Center, Amsterdam, Netherlands
[5
]Gastroenterology Department, Centro Hospitalar Universitário de São João, Porto, Portugal
[6
]Faculty of Medicine of the University of Porto, Porto, Portugal
[7
]Department of Medicine II, LMU Klinikum Munich, Munich, Germany
[8
]Eli Lilly and Company, Indianapolis, IN, USA
[9
]Università della Svizzera Italiana, Facoltà di Scienze Biomediche. Epatocentro, Lugano,
Switzerland
[10
]Department of Medicine, University Medical Center Hamburg-Eppendorf. Hamburg Center
for Translational Immunology. Martin Zeitz Center for Rare Diseases, University Medical
Center Hamburg-Eppendorf, Hamburg, Germany
[11
]Laboratory of Pathology, National Cancer Institute, National Institutes of Health,
Bethesda, USA
[12
]APHP, Hôpital Paul Brousse, Centre Hépato-Biliaire, INSERM Unit 1193, FHU Hepatinov,
Villejuif, France
[13
]Department of Clinical Pharmacology and Toxicology, University Hospital Zurich, University
of Zurich, Zurich, Switzerland
[14
]Department of Visceral Surgery and Medicine, Inselspital University Hospital and University
of Bern, Bern, Switzerland
[15
]Department of Gastroenterology and Hepatology, St. John’s Medical College Hospital,
Bangalore, India
[16
]Departments of Medicine and Surgery, Section of Gastroenterology and Hepatology and
Division of Abdominal Transplantation, Baylor College of Medicine, Houston, Texas,
United States
[17
]Hannover Medical School, Centre of ERN RARE-LIVER, Hannover, Germany
[18
]Department of Internal Medicine, University Medical Center Hamburg-Eppendorf; European
Reference Network on Hepatological Diseases (ERN RARE-LIVER), Hamburg, Germany
[19
]Liver Unit, Hospital Clínic de Barcelona, Health Care Provider of the European Reference
Network on Rare Liver Disorders (ERN-Liver), Institut d’ Investigacions Biomédiques
August Pi i Sunyer (IDIBAPS), Barcelona, Spain
[20
]Center for Drug Evaluation and Research, Office of Surveillance and Epidemiology,
US Food and Drug Administration, Silver Spring, Maryland, USA
[21
]Institute of Liver Studies, King’s College Hospital, London, UK
[22
]University School of Medicine & Indiana University Health, Indianapolis, Indiana,
USA
[23
]NIHR Birmingham BRC, Institute of Immunology and Immunotherapy, Centre for Liver and
Gastrointestinal Research; Liver Unit, University Hospitals Birmingham National Health
Service Foundation Trust Queen Elizabeth; Institute of Immunology and Immunotherapy;
Institute of Applied Health Research, University of Birmingham, Birmingham, UK
[24
]Division of Hepatology and Nutrition, Food and Drug Administration, Silver Spring,
Maryland, USA
[25
]Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School,
European Reference Network on Hepatological Diseases (ERN RARE-LIVER), Hannover, Germany
[26
]Division of Gastroenterology and Hepatology, University of Michigan Medical School,
Ann Arbor, MI, United States
[27
]Center for Liver and Gastro Research & National Institute of Health Research Birmingham
Biomedical Research Centre, University of Birmingham; Centre for Rare Disease and
ERN Rare Liver Centre, Liver Transplant and Hepatobiliary Unit, University Hospital
Birmingham NHS Foundation Trust, UK
[28
]Institute of Liver Studies, King’s College Hospital, London SE5 9RS, UK
[29
]Medicina Interna ed Epatologia, Università degli Studi di Palermo, Palermo, Italy
[30
]Platform ISCiii for Clinical Research and Clinical Trials SCReN UICEC- IBIMA, Málaga,
Spain
[31
]MowatLabs, Faculty of Life Sciences and Medicine, King’s College London, King’s College
Hospital, London, United Kingdom
[32
]Faculty of Medicine, University of Iceland, Department of Gastroenterology and Hepatology,
Landspitali University Hospital, Reykjavik, Iceland
[33
]Mechanistic Safety, Global Drug Development, Novartis, Basel, Switzerland
